ARCHIVES

Cobimetinib-Zelboraf Therapy Increases OS In BRAF V600 Mutation-Positive Disease

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

DCE Board Approves Concepts for More Chemoprevention Projects, NEW RFAs for PV, Anti-Sense RNA Studies

October 31, 1986

The Lancet Corrects Henschke Letters.

July 18, 2008

Clearinghouse Finds Seven Compounds Are Carcinogenic, Human Threat

September 1, 1978

ACCC Planning Session Considers Community Impact

August 31, 1979

Xeloda As Effective As 5-FU/LV, Five-Year Survival Data Show

September 28, 2007

Also in this 8-page issue: Amendment strips funding from two NIHM grants. NCI will commit $7 million to begin restructuring its clinical trials system, Institute director says.

July 1, 2005